De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study.
about
Etiologies of epilepsy: a comprehensive reviewVaccination safety updateA retrospective population-based study on seizures related to childhood vaccination.Benign convulsion with mild gastroenteritis.Long-term follow-up of febrile infection-related epilepsy syndrome.mRNA surveillance and endoplasmic reticulum quality control processes alter biogenesis of mutant GABAA receptor subunits associated with genetic epilepsies.Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome.The hidden genetics of epilepsy-a clinically important new paradigm.SCN1A Genetic Test for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy and its Clinical Subtypes) for use in the Diagnosis, Prognosis, Treatment and Management of Dravet SyndromePrevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort studyAltered GABA signaling in early life epilepsies.Genetic testing in epilepsy: what should you be doing?Inherited neuronal ion channelopathies: new windows on complex neurological diseases.Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology.Nav 1.1 dysfunction in genetic epilepsy with febrile seizures-plus or Dravet syndrome.Severe myoclonic epilepsy of infancy (Dravet syndrome): Clinical and genetic features of nine Turkish patients.Vaccines, encephalopathies, and mutations.Adversomics: a new paradigm for vaccine safety and design.Vaccination Triggers, Rather Than Causes, Seizures.When should clinicians order genetic testing for Dravet syndrome?Channelopathies in idiopathic epilepsy.Genetic variations and associated pathophysiology in the management of epilepsy.Hypotheses, tests, methods, and innovation: the balancing act in research.Genetics and the myth of vaccine encephalopathyVaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.Licensed pertussis vaccines in the United States. History and current state.Forty years from markers to genes.FIRST: a practical approach to the causes and management of febrile seizures.Effectiveness of pertussis vaccination and duration of immunity.Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort.Acellular and "low" pertussis vaccines: adverse events and the role of mutations.Clinical evaluation and diagnosis of severe epilepsy syndromes of early childhood.Severe epilepsy syndromes of early childhood: the link between genetics and pathophysiology with a focus on SCN1A mutations.NaV1.1 channels and epilepsy.Vaccinations and febrile seizures.Sodium channels and the neurobiology of epilepsy.Fever and fever-related epilepsies.Vaccines and febrile seizures.Epilepsy and vaccinations: Italian guidelines.Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome.
P2860
Q22305926-F4D0E4D2-04CB-4396-B8E0-C96959358758Q24646165-6E53700E-6CF5-4ECF-8C5C-1377676BA94BQ33160174-8E3CF1BF-8C31-452B-9601-C29EBB95FEBCQ34022925-53B03445-F384-4CAD-94E2-5912E62D5961Q34108682-70C05F8E-0D94-4542-99DD-5F3FF47471EDQ34315858-E2757626-298A-4149-A589-4F4822C92E20Q34359072-9198765C-7097-42D6-AB6A-8F94BD7F3DB4Q34415194-60FE145A-79EA-49F7-AF13-D5BE7A4261B8Q34709762-24E10201-789A-4457-81DC-A88C12374EADQ34770167-0BC81A57-96EA-4535-9152-7D7B95CE6235Q35147300-E167F1F7-E2C9-4947-938E-690D8CEC2C20Q35152981-1CC5C651-178A-4FD5-B69B-20EA5DA83774Q35226085-B6D09C75-D6D7-4190-833A-721E91B989FAQ35275382-ABF528EC-90FA-4B06-A54E-F840631C1B5CQ35375026-1AFE5C52-474E-47EA-88CB-9AD1FA032D25Q35430460-E51C3FEE-56E0-45B7-B867-3A1DDE808C41Q35788483-9E8ADC5D-C13A-41B0-83EE-2F6A570348D0Q36242667-7EF722F8-47EF-45C8-A982-F646AE892FFAQ36314744-57A116F5-82B3-44EF-A14E-38F6E2BAFF53Q36460682-90C77859-69A5-4FB5-A773-891DCEB33C59Q36774738-A18D5054-FA9F-48C8-B89D-18CF8E05FCD9Q36925220-506F9040-5BE2-4409-A10D-255421260DDDQ36941925-BA34E638-79DE-4709-AC77-CD9E9DB41038Q37016578-ECF595B5-24B0-4515-A235-AF61FABD44D2Q37119456-4AAE7688-5A7E-49BC-87E3-88468C66C63BQ37154787-AB3792BB-7A32-4F20-8A78-2D006054FDC9Q37220081-68181E4F-FC64-4FAB-A61C-9DE34AC8F020Q37346598-391244EC-103C-465D-A36E-A8A16CFC9A63Q37382056-14CEB96B-AFDF-405C-BD43-D614B683A117Q37455235-FAFD8701-F8C6-48D9-8AC7-667FA70FF966Q37529419-13FA33B2-FF44-4B50-A7D5-FD77788D9DCEQ37576847-D9CAC569-0BCE-44FF-BF43-0572DA9F9BA1Q37576848-E41B8756-DF02-4941-91AA-0E73D266C230Q37701079-5D7935B5-91F7-46B9-A225-59BAE6B8C57AQ37872028-806ED77D-A266-4B17-8002-349DF393A291Q38035905-B35AEAA1-2DC4-48C3-BBA6-220647BF3075Q38040439-FEDFB1EA-0255-49C1-8E40-654E54BE33D7Q38132266-8A68A6C3-C939-44A2-9E93-041045E38705Q38149917-C4DBBF60-ADD4-4E95-89C5-DB27B7A262A4Q39598983-E92272E9-2831-42DC-8C5E-F5185BDF70D5
P2860
De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
De-novo mutations of the sodiu ...... opathy: a retrospective study.
@en
De-novo mutations of the sodiu ...... opathy: a retrospective study.
@nl
type
label
De-novo mutations of the sodiu ...... opathy: a retrospective study.
@en
De-novo mutations of the sodiu ...... opathy: a retrospective study.
@nl
prefLabel
De-novo mutations of the sodiu ...... opathy: a retrospective study.
@en
De-novo mutations of the sodiu ...... opathy: a retrospective study.
@nl
P2093
P50
P1433
P1476
De-novo mutations of the sodiu ...... opathy: a retrospective study.
@en
P2093
Elaine C Wirrell
James T Pelekanos
John C Mulley
Louise Harkin
Sameer M Zuberi
Xenia Iona
P304
P356
10.1016/S1474-4422(06)70446-X
P577
2006-06-01T00:00:00Z